Trials in San Diego, California
Here are the top 10 medical studies for prostate cancer in San Diego, California
Popular Filters
Phase 3 Trials
Radioisotope Therapy
177Lu-PSMA-617 + Standard Therapy for Prostate Cancer
Recruiting2 awardsPhase 3
Orange, California
This trial tests if adding a radioactive drug to standard hormone treatments can better treat men with advanced prostate cancer. The drug targets and kills cancer cells with radiation, while standard treatments block hormones that help cancer grow.
Hormone Therapy
Fuzuloparib + AA-P for Prostate Cancer
Recruiting1 awardPhase 3
Rancho Mirage, California
This trial is testing whether a combination of Fuzuloparib and AA-P is better for treating advanced prostate cancer. The treatment aims to kill cancer cells by preventing them from fixing their damaged DNA and by reducing hormone levels that help the cancer grow. The study includes patients with and without specific DNA repair deficiencies.
Radioisotope Therapy
Lu-177 PSMA Therapy for Prostate Cancer
Recruiting2 awardsPhase 3
Newport Beach, California
This trial is testing a radioactive treatment in patients with advanced prostate cancer that hasn't responded to other treatments. The treatment targets and kills cancer cells using radiation and has shown promising outcomes, including reduced disease progression and improved overall survival.
Androgen Receptor Antagonist
Hormone + Radiation Therapy for Prostate Cancer
Recruiting2 awardsPhase 3
Orange, California
This trial is testing two different intensities of hormone therapy and radiation therapy, comparing them to the current standard of care, in order to determine the best treatment plan for patients with high risk prostate cancer.
AKT Inhibitor
Capivasertib + Abiraterone for Prostate Cancer
Recruiting1 awardPhase 3
San Diego, California
This trial will compare the efficacy of capivasertib+abiraterone+androgen deprivation therapy to placebo+abiraterone+androgen deprivation therapy in men with metastatic hormone-sensitive prostate cancer (mHSPC) whose tumours are PTEN-deficient. The primary endpoint is radiographic progression-free survival.
Trials With No Placebo
Radioisotope Therapy
177Lu-PSMA-617 + Standard Therapy for Prostate Cancer
Recruiting2 awardsPhase 3
Orange, California
This trial tests if adding a radioactive drug to standard hormone treatments can better treat men with advanced prostate cancer. The drug targets and kills cancer cells with radiation, while standard treatments block hormones that help cancer grow.
Radioisotope Therapy
Lu-177 PSMA Therapy for Prostate Cancer
Recruiting2 awardsPhase 3
Newport Beach, California
This trial is testing a radioactive treatment in patients with advanced prostate cancer that hasn't responded to other treatments. The treatment targets and kills cancer cells using radiation and has shown promising outcomes, including reduced disease progression and improved overall survival.
Small Molecule
PC14586 for Solid Tumors
Recruiting1 awardPhase 1 & 2
La Jolla, California
This trial is testing a new oral drug, PC14586 (rezatapopt), alone and with pembrolizumab, in patients with advanced cancers that have a specific genetic mutation. The drug aims to fix a mutated protein to help control cancer growth. The study will determine the best dose and evaluate the drug's safety and effectiveness.
Behavioural Intervention
White Button Mushroom Extract for Prostate Cancer
Recruiting1 awardPhase 2
Irvine, California
This trial studies if a white button mushroom supplement can lower PSA levels in patients with recurrent or newly diagnosed prostate cancer. The supplement may also impact the immune system and hormone levels. White button mushrooms (Agaricus bisporus) have been studied for their potential effects on prostate-specific antigen (PSA) levels in prostate cancer patients.
Androgen Receptor Antagonist
Hormone + Radiation Therapy for Prostate Cancer
Recruiting2 awardsPhase 3
Orange, California
This trial is testing two different intensities of hormone therapy and radiation therapy, comparing them to the current standard of care, in order to determine the best treatment plan for patients with high risk prostate cancer.
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.